Τετάρτη 8 Φεβρουαρίου 2017

Photodynamic therapy for low risk prostate cancer

Prostate cancer is the second most common cancer in men. However, a substantial proportion of the cancers diagnosed annually are low risk: clinical stage ≤T2, prostate specific antigen (PSA) recent?d=yIl2AUoC8zA recent?d=dnMXMwOfBR0 recent?i=hIgYbZQ0Gos:w_RMbNbpxbw:V_sGLiP recent?d=qj6IDK7rITs recent?i=hIgYbZQ0Gos:w_RMbNbpxbw:gIN9vFw recent?d=l6gmwiTKsz0 recent?d=7Q72WNTAKBA recent?i=hIgYbZQ0Gos:w_RMbNbpxbw:F7zBnMy recent?i=hIgYbZQ0Gos:w_RMbNbpxbw:-BTjWOF

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2klCOLq
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις